Neurobiology of Aging · 2017 · 58 citations · 16 references
Life SciencesGeneticsNeurologyHuman GeneticsMedical GeneticsNeurogeneticsGenetic DisordersGenetic SusceptibilityNeurodegenerative Disease GeneticsNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenetic DisordersFrontotemporal Dementia DiagnosisFrontotemporal Dementia EpidemiologyGenetic Modifier EffectsGrn MutationsMolecular Diagnostics In NeurogeneticsNeurodegeneration GeneticsNeurodegenerative GeneticsProgranulin-related Frontotemporal Dementia
We investigated whether progranulin plasma levels are predictors of the presence of progranulin gene (GRN) null mutations or of the development of symptoms in asymptomatic at risk members participating in the Genetic Frontotemporal Dementia Initiative, including 19 patients, 64 asymptomatic carriers, and 77 noncarriers. In addition, we evaluated a possible role of TMEM106B rs1990622 as a genetic modifier and correlated progranulin plasma levels and gray-matter atrophy. Plasma progranulin mean ± SD plasma levels in patients and asymptomatic carriers were significantly decreased compared with noncarriers (30.5 ± 13.0 and 27.7 ± 7.5 versus 99.6 ± 24.8 ng/mL, p < 0.00001). Considering the threshold of >61.55 ng/mL, the test had a sensitivity of 98.8% and a specificity of 97.5% in predicting the presence of a mutation, independent of symptoms. No correlations were found between progranulin plasma levels and age, years from average age at onset in each family, or TMEM106B rs1990622 genotype (p > 0.05). Plasma progranulin levels did not correlate with brain atrophy. Plasma progranulin levels predict the presence of GRN null mutations independent of proximity to symptoms and brain atrophy.
16
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Manuela Neumann, Deepak M. Sampathu, Linda K. Kwong et al. · Science · 2006 · 6.6K citations
Wei Tang, Yi Lu, Qingyun Tian et al. · Science · 2011 · 778 citations · Full text
Jonathan D. Rohrer, Jennifer Nicholas, David M. Cash et al. · The Lancet Neurology · 2015 · 544 citations · Full text
Life Sciences, Genetics, Neurology +17
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
Roberta Ghidoni, Luisa Benussi, Michela Glionna et al. · Neurology · 2008 · 298 citations
Life Sciences, Genetics, Neurology +16